Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The primary efficacy assessment for each of these studies was the percent change from baseline to Week 26 (Main Phase) in visceral adipose tissue (VAT), as assessed by computed tomography (CT) scan at L4-L5 vertebral level
Pick up is available from our store
Explore CJC-1295 as the standard Ipamorelin combination partner Tesamorelin FDA-approved GHRH analog with an established clinical evidence base for GH-related visceral fat reduction, representing an alternative GHRH-class option in physician-supervised GH optimization protocols
Sustainability 10, 391
US$ 23.29
US$ 29.48
US$ 29.14
US$ 29.03
